title: 3 Reasons To Be Optimistic Around Biotech In Q4
source: SeekingAlpha
date: 2025-10-05
url: https://finnhub.io/api/news?id=2ac641d585eaf5678cb0305799e04c8c404c8ec9ed381254d4b00937ae526469
Biotech is outperforming the S&P 500 and NASDAQ as M&A heats up and Q4 tailwinds emerge, signaling more upside ahead. Read more on the sector breakdown here.
